Smith & Nephew (SNN) Total Liabilities (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Total Liabilities of $5.2 billion for Q4 2025, up 1.55% year-on-year from $5.1 billion in Q4 2024, and little changed on a QoQ basis from $5.2 billion in Q2 2025.
Smith & Nephew (SNN) Total Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Total Liabilities for 17 consecutive years, with $5.2 billion the latest figure, recorded in Q4 2025.
- Quarterly Total Liabilities rose 1.55% year-over-year to $5.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.2 billion (up 1.55% YoY) and the FY2025 annual result came in at $5.2 billion, up 1.55% from the prior year.
- Total Liabilities steadied at $5.2 billion in Q4 2025 per SNN's latest filing, from $5.2 billion in the prior quarter.
- Over the last five years, Total Liabilities for SNN reached as high as $5.3 billion in Q2 2024 and fell as low as $32.0 million in Q4 2023.
- A 5-year average of $3.0 billion and a median of $5.1 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities plunged 58.97% — and 2024, when it surged 15803.12%.
- Year by year, Total Liabilities stood at $84.0 million in 2021, then dropped by 7.14% to $78.0 million in 2022, then tumbled by 58.97% to $32.0 million in 2023, then jumped by 15803.12% to $5.1 billion in 2024, then rose by 1.55% to $5.2 billion in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $5.2 billion, $5.2 billion, and $5.1 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 3.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.17 Bn |
| Jun 28, 2025 | 5.16 Bn |
| Dec 31, 2024 | 5.09 Bn |
| Jun 29, 2024 | 5.34 Bn |
| Dec 31, 2023 | 32.00 Mn |
| Dec 31, 2022 | 78.00 Mn |
| Dec 31, 2021 | 84.00 Mn |
| Dec 31, 2020 | 128.00 Mn |
| Jun 30, 2020 | 4.58 Bn |
| Dec 31, 2019 | 141.00 Mn |
| Jun 29, 2019 | 3.99 Bn |
| Dec 31, 2018 | 99.00 Mn |
| Jun 30, 2018 | 3.07 Bn |
| Dec 31, 2017 | 104.00 Mn |
| Dec 31, 2016 | 3.39 Bn |
| Dec 31, 2015 | 3.20 Bn |
| Jun 30, 2015 | 3.17 Bn |
| Dec 31, 2014 | 3.27 Bn |
| Sep 30, 2014 | 3.63 Bn |
| Jun 28, 2014 | 3.59 Bn |